Paris Olympics: Swimmers from China set for twice as many doping tests as others amid doping controversy
Chinese swimmers will have undergone at least eight drug tests by the start of the Paris Olympics, twice as many as athletes from other countries. The sport’s governing body, World Aquatics, was under pressure to act after 23 Chinese swimmers tested positive for a banned substance, heart medication trimetazidine, seven months before the 2021 Tokyo Olympics, but were cleared of wrongdoing and went on to claim three gold medals. Eleven of them are competing in Paris this month.
After a review of its decision allowing the swimmers to compete in Tokyo, World Aquatics said the incident “weakened” trust in the anti-doping system. To rebuild trust, it said, Chinese swimmers competing in Paris will have been tested “no less than eight times” this year by the International Testing Agency, twice the standard level. It said “a certain number of athletes from specific nations will be tested four times” by the agency which runs anti-doping programmes for many Olympic sports.
Samples of Chinese athletes will ideally not be collected by the Chinese anti-doping agency and not be tested by laboratories in China. World Aquatics is likely to publish the results of the tests before the Olympics opening ceremony next week.
The body is seeking to reassure the world of sport of its fairness after Michael Phelps, the most decorated athlete in Olympic history with 28 medals, said the World Anti-Doping Agency, which conducted the 2021 tests, can no longer be trusted. It was also targeted by a US federal investigation for accepting the
